In situ Delivery of Tumor Antigen- and Adjuvant-Loaded Liposomes Boosts Antigen-Specific T-Cell Responses by Human Dermal Dendritic Cells

Journal of Investigative Dermatology

Volumn 135, Issue 11, 2015, Pages 2697-2704

  Boks, Martine A ^a   Bruijns, Sven C M ^a   Ambrosini, Martino ^a   Kalay, Hakan ^a   Van Bloois, Louis ^b   Storm, Gert ^b,c   De Gruijl, Tanja ^a   Van Kooyk, Yvette ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN GP 100; INTERLEUKIN 6; INTERLEUKIN 8; MELANOMA ANTIGEN; MELANOMA ASSOCIATED ANTIGEN GLYCOPROTEIN 100 280 288 PEPTIDE; PHOSPHORYL LIPID A; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CANCER VACCINE; LIPOSOME; TOLL LIKE RECEPTOR; TUMOR ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNIZATION; CD8+ T LYMPHOCYTE; CELL MATURATION; CROSS PRESENTATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DOSE RESPONSE; HUMAN; HUMAN TISSUE; INTERNALIZATION; LIPID BILAYER; MONOCYTE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CELL; ZETA POTENTIAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOTHERAPY; NEEDLE BIOPSY; PATHOLOGY; PROCEDURES; SKIN;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BIOPSY, NEEDLE; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CROSS-PRIMING; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LIPOSOMES; SKIN; TOLL-LIKE RECEPTORS;

EID: 84947020324     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.226     Document Type: Article

References (32)

1. Appay V, Douek DC, Price DA (2008) CD8+ T cell efficacy in vaccination and disease. Nat Med 14:623-8
2. Banchereau J, Briere F, Caux C et al. (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811
3. Carbone FR, Bevan MJ (1990) Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med 171:377-87
4. Fehres CM, Bruijns SC, van Beelen AJ et al. (2014) Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8 T-cell cross-priming. Eur J Immunol 8:2415-24
5. Fehres CM, Garcia-Vallejo JJ, Unger WWJ et al. (2013) Skin-resident antigenpresenting cells: instruction manual for vaccine development. Front Immunol 4:157
6. Gluckman JC, Canque B, Chapuis F et al. (1997) In vitro generation of human dendritic cells and cell therapy. Cytokines Cell Mol Ther 3:187-96
7. Harman AN, Bye CR, Nasr N et al. (2013) Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J Immunol 190:66-79
8. Janeway CA, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216
9. Jensen PE (2007) Recent advances in antigen processing and presentation. Nat Immunol 8:1041-8
10. Jerome V, Graser A, Muller R et al. (2006) Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant. J Immunother 29:294-305
11. Joffre OP, Segura E, Savina A et al. (2012) Cross-presentation by dendritic cells. Nat Rev Immunol 12:557-69
12. Joshi MD, UngerWJ, Storm G et al. (2012) Targeting tumor antigens to dendritic cells using particulate carriers. J Control Release 161:25-37
13. Joshi MD, Unger WW, van Beelen AJ et al. (2011) DC-SIGN mediated antigentargeting using glycan-modified liposomes: formulation considerations. Int J Pharm 416:426-32
14. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373-84
15. Klechevsky E, Morita R, Liu M et al. (2008) Functional specializations of human epidermal langerhans cells and CD14+ dermal dendritic cells. Immunity 29:497-510
16. Matthews K, Chung NP, Klasse PJ et al. (2012) Potent induction of antibodysecreting B cells by human dermal-derived CD14+ dendritic cells triggered by dual TLR ligation. J Immunol 189:5729-44
17. McGovern N, Schlitzer A, Gunawan M et al. (2014) Human dermal CD14(+) cells are a transient population of monocyte-derived macrophages. Immunity 41:465-77
18. Nair-Gupta P, Baccarini A, Tung N et al. (2014) TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation. Cell 158:506-21
19. Nestle FO, Zheng XG, Thompson CB et al. (1993) Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 151:6535-45
20. Oosterhoff D, Heusinkveld M, SaM Lougheed et al. (2013) Intradermal delivery of TLR agonists in a human explant skin model: preferential activation of migratory dendritic cells by polyribosinic-polyribocytidylic acid and peptidoglycans. J Immunol 190:3338-45
21. Romani N, Gruner S, Brang D et al. (1994) Proliferating dendritic cell progenitors in human blood. J Exp Med 1:83-93
22. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 4:1109-18
23. Schaft N, Willemsen RA, de Vries J et al. (2003) Peptide fine specificity of antiglycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes. J Immunol 170:2186-94
24. Schlosser E, Mueller M, Fischer S et al. (2008) TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 26: 1626-37
25. Schneider LP, Schoonderwoerd AJ, Moutaftsi M et al. (2012) Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cells. Vaccine 30:4216-24
26. Segura E, Valladeau-Guilemond J, Donnadieu MHln et al. (2012) Characterization of resident and migratory dendritic cells in human lymph nodes. J Exp Med 209:653-60
27. Seneschal J, Clark RA, Gehad A et al. (2012) Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36:873-84
28. Steinhagen F, Kinjo T, Bode C et al. (2011) TLR-based immune adjuvants. Vaccine 29:3341-55
29. Torchilin VP (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145-60
30. van de Ven R, van den Hout MFCM, Lindenberg JJ et al. (2011) Characterization of four conventional dendritic cell subsets in human skindraining lymph nodes in relation to T-cell activation. Blood 118: 2502-10
31. van der Aar AM, Sylva-Steenland RM, Bos JD et al. (2007) Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J Immunol 178:1986-90
32. Wakim LM, Waithman J, van RN et al. (2008) Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 319:198-202